Eli Lilly’s much-anticipated obesity pill falls short of Wegovy

[ad_1] Eli Lilly’s investigational obesity pill led to less weight loss in a late-stage trial than the reductions seen with injectable treatments on the market, results that weaken its competitiveness as one of Lilly’s most-anticipated candidates. After 72 weeks, patients taking the highest dose of the therapy, called orforglipron, experienced 11.2% weight loss, when analyzing…

Read More

RFK Jr. could remake preventive services task force ‘imminently’| STAT

[ad_1] WASHINGTON — Health secretary Robert F. Kennedy Jr. could “imminently” overhaul a key federal advisory panel that recommends which preventive services insurers must pay for, according to a person familiar with the plans.  The person said that federal health officials are actively vetting new members for the U.S. Preventive Services Task Force. David Mansdoerfer,…

Read More